TRIAMCINOLONE-MOXIFLOXACIN PF injection, suspension

देश: संयुक्त राज्य

भाषा: अंग्रेज़ी

स्रोत: NLM (National Library of Medicine)

सक्रिय संघटक:

TRIAMCINOLONE ACETONIDE (UNII: F446C597KA) (TRIAMCINOLONE ACETONIDE - UNII:F446C597KA), MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE (UNII: B8956S8609) (MOXIFLOXACIN - UNII:U188XYD42P)

थमां उपलब्ध:

Imprimis NJOF, LLC

INN (इंटरनेशनल नाम):

TRIAMCINOLONE ACETONIDE

रचना:

TRIAMCINOLONE ACETONIDE 15 mg in 1 mL

प्रशासन का मार्ग:

OPHTHALMIC

प्रिस्क्रिप्शन प्रकार:

PRESCRIPTION DRUG

प्राधिकरण का दर्जा:

unapproved drug other

उत्पाद विशेषताएं

TRIAMCINOLONE-MOXIFLOXACIN PF- TRIAMCINOLONE-MOXIFLOXACIN PF
INJECTION,
SUSPENSION
IMPRIMIS NJOF, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
STORE AT 20° TO 25° C (68° TO 77° F)
PACKAGE LABEL
TRIAMCINOLONE-MOXIFLOXACIN PF
triamcinolone-moxifloxacin pf injection, suspension
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:7138 4-510
ROUTE OF ADMINISTRATION
OPHTHALMIC
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
TRIAMCINO LO NE ACETO NIDE (UNII: F446 C59 7KA) (TRIAMCINOLONE
ACETONIDE - UNII:F446 C59 7KA)
TRIAMCINOLONE ACETONIDE
15 mg
in 1 mL
MO XIFLO XACIN HYDRO CHLO RIDE MO NO HYDRATE (UNII: B8 9 56 S8 6 0 9 )
(MOXIFLOXACIN - UNII:U18 8 XYD42P)
MOXIFLOXACIN HYDROCHLORIDE
MONOHYDRATE
1 mg
in 1 mL
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:7138 4-510 -
0 1
20 in 1 BOX
0 1/0 5/20 18
Imprimis NJOF, LLC
1
0 .6 mL in 1 VIAL, SINGLE-USE; Type 0 : No t a Co mbinatio n
Pro duc t
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 1/0 5/20 18
LABELER -
Imprimis NJOF, LLC (080431967)
REGISTRANT -
Imprimis NJOF, LLC (080431967)
Revised: 2/2020